Fintel reports that on October 21, 2024, Mizuho initiated coverage of BKV (NYSE:BKV) with a Outperform recommendation. What ...

Fintel reports that on October 21, 2024, Keybanc initiated coverage of BKV (NYSE:BKV) with a Overweight recommendation. What ...

KeyBanc Capital Markets initiated coverage of BKV Corp. (NYSE:BKV) with an "overweight" rating and set a price target of $23 per share. BKV stands out due to its dual business model, which integrates ...

KeyBanc initiated coverage of BKV Corp. (BKV) with an Overweight rating and $23 price target BKV is primarily a natural gas-focused ...

Mizuho initiated coverage of BKV Corp. (BKV) with an Outperform rating and $29 price target Although the company’s three business units ...

DENVER, September 25, 2024--(BUSINESS WIRE)--BKV Corporation ("BKV") today announced the pricing of its initial public ...

DENVER, September 27, 2024--(BUSINESS WIRE)--BKV Corporation ("BKV") (NYSE: BKV) today announced the closing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per ...

Sept 26 (Reuters) - Shares of BKV (BKV.N), opens new tab rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas producer a market capitalization of $1.56 ...

Obesity-drug developer BioAge holds on to a slim gain, while Texas-based Barnett Shale driller BKV trades flat Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell ...

Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted.

BKV Corporation (“BKV”) today announced the pricing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per share. The underwriters will have a 30-day option to ...

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV”) (NYSE: BKV) today announced the closing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per share.